Recombinant Human Cathepsin B Protein, CF Summary
Product Specifications
Arg18-Ile339 (pro) & Phe74-Ile339 (mature), both with a C-terminal 10-His tag
Analysis
Product Datasheets
953-CY
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
953-CY
Formulation | Supplied as a 0.2 μm filtered solution in Tris and NaCl. |
Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Assay Procedure
- Activation Buffer: 25 mM MES, 5 mM DTT, pH 5.0
- Assay Buffer: 25 mM MES, pH 5.0
- Recombinant Human Cathepsin B (rhCathepsin B) (Catalog # 953-CY)
- Fluorogenic Peptide Substrate VII: Z-Leu-Arg-AMC (Catalog # ES008)
- F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
- Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
- Dilute rhCathepsin B to 10 µg/mL in Activation Buffer.
- Incubate at room temperature for 15 minutes.
- Dilute rhCathepsin B to 0.2 ng/µL in Assay Buffer.
- Dilute substrate to 20 µM in Assay Buffer.
- Load 50 µL of the 0.2 ng/µL rhCathepsin B in a black well plate, and start the reaction by adding 50 µL of 20 µM Substrate. Include a Substrate Blank containing 50 µL Assay Buffer and 50 µL of 20 µM Substrate without any rhCathepsin B.
- Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively, in kinetic mode for 5 minutes.
Calculate specific activity:
Specific Activity (pmol/min/µg) = |
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU) |
amount of enzyme (µg) |
*Adjusted for Substrate Blank
**Derived using calibration standard 7-Amino, 4-Methyl Coumarin (AMC) (Sigma, Catalog # A-9891).
Per Well:- rhCathepsin B: 0.01 µg
- Substrate: 10 µM
Background: Cathepsin B
Cathepsin B is the first described member of the family of lysosomal cysteine proteases (1). Cathepsin B possesses both endopeptidase and exopeptidase activities, in the latter case acting as a peptidyl-dipeptidase. It is known to process a number of proteins, including pro and active caspases, prorenin and secretory leucoprotease inhibitor (SLPI) (2 - 4). Therefore, Cathepsin B may play a role in activation and inactivation of caspases, activation of renin and inactivation of SLPI, the key steps in apoptosis, angiotensin production, and progression of emphysema, respectively. Because of its increased levels and redistribution of the enzyme in human and animal tumors, Cathepsin B may also have role in invasion and metastasis (5).
In addition to lysosome, Cathepsin B can be secreted or associated with plasma membrane, cytoplasm, and nucleus. It is synthesized as a preproenzyme. Following removal of the signal peptide, the inactive proenzyme undergoes further modifications including removal of the pro region to result in the active enzyme (1).
- Mort, J.S. (2004) in Handbook of Proteolytic Enzymes. Barrett, A.J. et al. (eds): Academic Press, San Diego, p. 1079.
- Vancompernolle, K. et al. (1998) FEBS Lett. 438:150.
- Jutras, I. and T.L. Reudelhuber (1999) FEBS Lett. 443:48.
- Taggart, C.C. et al. (2001) J. Biol. Chem. 276:33345.
- Bergquin, I.M. and B.F. Sloane (1996) Adv. Exp. Med. Biol. 389:281.
Citations for Recombinant Human Cathepsin B Protein, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
16
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy
Authors: Kim, J;Song, S;Gwak, M;Cho, H;Yun, WS;Hwang, N;Kim, J;Lee, JS;Kim, DH;Kim, H;Jeon, SI;Kim, TI;Kim, K;
Biomaterials research
Species: N/A
Sample Types: Peptides
Applications: Bioassay -
Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis
Authors: W Deng, Y Bai, F Deng, Y Pan, S Mei, Z Zheng, R Min, Z Wu, W Li, R Miao, Z Zhang, TS Kupper, J Lieberman, X Liu
Nature, 2022-02-02;0(0):.
Species: Human
Sample Types: Recombinant Protein
Applications: Bioassay -
The effects of Cstb duplication on APP/amyloid-beta pathology and cathepsin B activity in a mouse model
Authors: Y Wu, HT Whittaker, S Noy, K Cleverley, V Brault, Y Herault, EMC Fisher, FK Wiseman
PLoS ONE, 2021-07-22;16(7):e0242236.
Species: Human
Sample Types: Tissue Homogenates
Applications: ELISA Standard -
Giant magnetoresistive biosensors for real-time quantitative detection of protease activity
Authors: S Adem, S Jain, M Sveiven, X Zhou, AJ O'Donoghue, DA Hall
Sci Rep, 2020-05-14;10(1):7941.
Species: Human
Sample Types: Urine
Applications: Bioassay -
Human Cysteine Cathepsins Degrade Immunoglobulin G In Vitro in a Predictable Manner
Authors: RA Høglund, SB Torsetnes, A Lossius, B Bogen, EJ Homan, R Bremel, T Holmøy
Int J Mol Sci, 2019-09-29;20(19):.
Species: Human
Sample Types: Protein
Applications: Bioassay -
Eradication of unresectable liver metastasis through induction of tumour specific energy depletion
Authors: D Huo, J Zhu, G Chen, Q Chen, C Zhang, X Luo, W Jiang, X Jiang, Z Gu, Y Hu
Nat Commun, 2019-07-11;10(1):3051.
Species: Human
Sample Types: Nanoparticles
Applications: Bioassay -
In vivo and in vitro anti-inflammatory and pro-osteogenic effects of citrus cystatin CsinCPI-2
Authors: NDP Leguizamón, EM Rodrigues, ML de Campos, AVB Nogueira, KS Viola, VK Schneider, DM Neo-Justin, M Tanomaru-F, WF Zambuzzi, F Henrique-S, A Soares-Cos, G Faria, JA Cirelli
Cytokine, 2019-06-18;123(0):154760.
Species: Human
Sample Types: Peptide
Applications: Bioassay -
The lysosomal protein cathepsin L is a progranulin protease
Authors: CW Lee, JN Stankowski, J Chew, CN Cook, YW Lam, S Almeida, Y Carlomagno, KF Lau, M Prudencio, FB Gao, M Bogyo, DW Dickson, L Petrucelli
Mol Neurodegener, 2017-07-25;12(1):55.
Species: Human
Sample Types: Protein
Applications: Bioassay -
Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response
Authors: BM Larimer, E Wehrenberg, F Dubois, A Mehta, T Kalomeris, K Flaherty, G Boland, U Mahmood
Cancer Res., 2017-05-01;77(9):2318-2327.
Applications: Bioassay -
Endosomal acidification and cathepsin L activity is required for calicivirus replication.
Authors: Shivanna V, Kim Y, Chang K
Virology, 2014-08-09;464(0):287-95.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
Cathepsin K-mediated Notch1 activation contributes to neovascularization in response to hypoxia.
Authors: Jiang H, Cheng X, Shi G, Hu L, Inoue A, Yamamura Y, Wu H, Takeshita K, Li X, Huang Z, Song H, Asai M, Hao C, Unno K, Koike T, Oshida Y, Okumura K, Murohara T, Kuzuya M
Nat Commun, 2014-06-04;5(0):3838.
Species: Mouse
Sample Types: Tissue Homogenates
Applications: Bioassay -
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth.
Authors: Bruchard M, Mignot G, Derangere V, Chalmin F, Chevriaux A, Vegran F, Boireau W, Simon B, Ryffel B, Connat J, Kanellopoulos J, Martin F, Rebe C, Apetoh L, Ghiringhelli F
Nat Med, 2012-12-02;19(1):57-64.
Species: Human
Sample Types: N/A
Applications: Surface Plasmon Resonance -
Fine-tuning nucleophosmin in macrophage differentiation and activation.
Authors: Guery L, Benikhlef N, Gautier T, Paul C, Jego G, Dufour E, Jacquel A, Cally R, Manoury B, Vanden Berghe T, Vandenabeele P, Droin N, Solary E
Blood, 2011-08-29;118(17):4694-704.
Species: Human
Sample Types: Recombinant Protein
Applications: Enzyme Assay -
Design of protease-resistant myelin basic protein-derived peptides by cleavage site directed amino acid substitutions.
Authors: Burster T, Marin-Esteban V, Boehm BO, Dunn S, Rotzschke O, Falk K, Weber E, Verhelst SH, Kalbacher H, Driessen C
Biochem. Pharmacol., 2007-08-02;74(10):1514-23.
Species: Human
Sample Types: Cell Lysates
Applications: Enzyme Assay -
Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.
Authors: Cheng T, Hitomi K, van Vlijmen-Willems IM, de Jongh GJ, Yamamoto K, Nishi K, Watts C, Reinheckel T, Schalkwijk J, Zeeuwen PL
J. Biol. Chem., 2006-03-24;281(23):15893-9.
Species: Human
Sample Types: Recombinant Protein
Applications: Enzyme Assay -
Distinct roles for cysteine cathepsin genes in multistage tumorigenesis.
Authors: Gocheva V, Zeng W, Ke D, Klimstra D, Reinheckel T, Peters C, Hanahan D, Joyce JA
Genes Dev., 2006-02-15;20(5):543-56.
Species: Human
Sample Types: Buffer
Applications: Enzyme Assay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human Cathepsin B Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Cathepsin B Protein, CF and earn rewards!
Have you used Recombinant Human Cathepsin B Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image